P S Goedegebuure - Concepedia

Author

P S Goedegebuure

Brigham and Women's Hospital

Also Known As

P S Goedegebuure, P. S. Goedegebuure, Peter S. Goedegebuure

Publications

527

Citations

H-Index

Concepts

All Affiliations

Brigham and Women's Hospital Harvard University United States Army Medical Command United States Army Institute of Surgical Research

About

P S Goedegebuure is an author at Brigham and Women's Hospital specializing in medicine, immunology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	349
2	Cell Biology	4	4	177
3	Immunology	4	4	334
4	Health Sciences	1	1	15
5	Molecular Biology	1	1	15

P S Goedegebuure

Publications

508

Citations

H-Index

Page 1

	Year	Citations
HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer. Ichiro Yoshino, P S Goedegebuure, George E. Peoples, PubMed Cancer ImmunosurveillanceOncogenic AgentMedicineImmunologyTumor Immunity	1994	172
HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer. George E. Peoples, P S Goedegebuure, John Andrews, The Journal of Immunology HlaHistocompatibilityEndogenous ProteinsSolid PhaseHla Immunogenetics	1993	72
T-cell recognition of ovarian cancer. George E. Peoples, Deric D. Schoof, John Andrews, PubMed	1993	62
CD4+ T Cell Clones Isolated from Human Renal Cell Carcinoma Possess the Functional Characteristics of Th2 Helper Cells Deric D. Schoof, Yasunori Terashima, George E. Peoples, Cellular Immunology Functional CharacteristicsTh2 Helper CellsCancer ImmunosurveillanceT-regulatory CellImmunology	1993	55
TCR V <i>beta</i> 3+ and V <i>beta</i> 6+ CTL recognize tumor-associated antigens related to HER2/ <i>neu</i> expression in HLA-A2+ ovarian cancers. George E. Peoples, Ichiro Yoshino, Cara C. Douville, The Journal of Immunology	1994	36
Human tumor-infiltrating CD4+ T cells react to B cell lines expressing heat shock protein 70. Ichiro Yoshino, P S Goedegebuure, GE Peoples, The Journal of Immunology Radiation OncologyTil LinesCancer ImmunosurveillanceT CellsT-regulatory Cell	1994	35
T cell receptor V <i>beta</i> 2 and V <i>beta</i> 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer. George E. Peoples, Michael P. Davey, P S Goedegebuure, The Journal of Immunology	1993	29
Induction of lysis by T cell receptor <i>gamma delta</i>+/CD3+ T lymphocytes via CD2 requires triggering via the T11.1 epitope only. P S Goedegebuure, David M. Segal, E Braakman, The Journal of Immunology	1989	19
Clone 10d/BM28 (CDCL1), an early S-phase protein, is an important growth regulator of melanoma. Remco A. Spanjaard, P J Lee, S Sarkar, PubMed Retinoic AcidMolecular BiologyCell ProliferationCancer BiologyTumor Biology	1997	15
Pancreatic cancer associated ascites-derived CTL recognize a nine-amino-acid peptide GP2 derived from HER2/neu. Matthias Peiper, P S Goedegebuure, Jakob R. Izbicki, PubMed	1999	13

Page 1